Background: Diagnostic radioiodine whole-body scanning (DxWBS) in combination with
stimulated thyroglobulin (Tg)(ie, measurement after levothyroxine [L-T4] withdrawal or …

Follow-up diagnostic radioiodine whole-body scintigraphy (DxWBS) is still advised for high-
risk patients with differentiated thyroid cancer. The aim of this study was to evaluate the …

Background: A diagnostic whole-body scan (WBS) is recommended 6 to 12 months after
total thyroidectomy and radioactive iodide ablation in intermediate-or high-risk patients with …

Objective To investigate predictors for successful ablation and disease-free status after high-
dose radioiodine therapy in patients with differentiated thyroid cancer. Methods We enrolled …

Background The most important part of the follow-up of differentiated thyroid carcinoma
(DTC) is the measurement of serum thyroglobulin (Tg). An increase of Tg levels indicates …

Background: Recently, there has been a trend to reduce the use of radioiodine remnant
ablation (RRA) in patients with low-risk (LR) and intermediate-risk (IR) differentiated thyroid …

Aim: to determine whether the first three months after 131I ablation is too early to perform
radioiodine diagnostic whole body scintigraphy (dxWBS) in differentiated thyroid carcinoma …

Purpose 131 I whole-body scan (WBS) and serum thyroglobulin (TG) are important in
detecting thyroid remnants or recurrent disease in patients with differentiated thyroid cancer …

Results During mean follow-up of 13.7±4.2 years, 20% of patients developed recurrence. At
the end of follow-up, 21% of patients had persistent disease. The clinical and histological …

Purpose The aim of our study was to compare the efficacy of thyroid remnant ablation using
low (1.1 GBq) and intermediate-high radioiodine (RAI) activity (1.85–3.7 GBq) in low-risk …